Deutsch
Nederlands
Turkish
Russian
Italiano
Français
Português
العربيةWhat we treat
- Home
- What we treat
Recent Posts
- Why are IQ scores declining over the previous 20 years?
- Expert report regarding the clinical use of CBD
- CBD effective in Healing Bone Fractures at all Ages and Prevention and Cure of Osteoporosis and Arthrosis
- Medical Cannabis Approval Sweeps Across Europe
- More people die from overdosing on pharmaceutical drugs than illegal drugs
- Flu vaccine BOMBSHELL: 630% more “aerosolized flu virus particles” emitted by people who received flu shots… flu vaccines actually SPREAD the flu
- The Vaccine Program’s Unintended Consequences: A Tale of Two Hepatitis B Studies:
Doctors who apply the Gorter Model can treat very well patients from the following areas:
- Oncology
- Chronic degenerative diseases
- HIV-AIDS
- Hepatitis B/C
Since 2001, more than 4000 patients were treated according to the Gorter Model so far. 96% of these patients lived in terminal stages with no remaining therapeutic options. However, they frequently experienced partial remission and stabilize for several years with a very positive quality of life. Numerous patients experienced even sustained and complete remission.
The treatment implies hope, although not all patients improve. However, the cancer therapy here offered is non-toxic and does not debilitate patients. Even patients with stage IV cancer and have a life expectancy of three to six months maximum often report that they feel a certain sense of vitality and are able to maintain or improve their quality of life throughout much of the course of their illness.
Experts expect that within a few years, dendritic cells will become a part of the standard treatment of various forms of cancer. Dr. Gorter states that:
“The Gorter Model promotes especially immune therapies that are natural and non-toxic cancer, and where dendritic cells play a crucial role. Among oncologists around the world, the consensus is that very soon the application of dendritic cells in cancer patients is the future.”